These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3520828)

  • 1. Lymphokines: from conjecture to the clinic.
    Gillis S; Conlon PJ; Cosman D; Hopp TP; Dower SK; Price V; Mochizuki DY; Urdal DL
    Semin Oncol; 1986 Jun; 13(2):218-27. PubMed ID: 3520828
    [No Abstract]   [Full Text] [Related]  

  • 2. The myeloid colony-stimulating factors: introduction and overview.
    Peters WP
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):1-5. PubMed ID: 1712123
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors and cancer chemotherapy.
    Lancet; 1991 Jul; 338(8761):217-8. PubMed ID: 1676781
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development.
    Bonnem EM; Morstyn G
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):46-51. PubMed ID: 3057644
    [No Abstract]   [Full Text] [Related]  

  • 6. CSFs, from basic science to clinical trials.
    Aglietta M; Gavosto F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():16-8. PubMed ID: 2653496
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Kupper T; Flood P; Coleman D; Horowitz M
    J Immunol; 1987 Jun; 138(12):4288-92. PubMed ID: 2953804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic growth factors.
    Sieff CA
    J Clin Invest; 1987 Jun; 79(6):1549-57. PubMed ID: 3034976
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation.
    Kaushansky K; Lin N; Adamson JW
    J Clin Invest; 1988 Jan; 81(1):92-7. PubMed ID: 2447127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant GM-CSF in myelosuppression of chemotherapy.
    N Engl J Med; 1989 Jan; 320(4):253-4. PubMed ID: 2643049
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation.
    Peters WP; Kurtzberg J; Atwater S; Borowitz M; Rao M; Currie M; Gilbert C; Shpall EJ; Jones RB; Ross M
    Prog Clin Biol Res; 1990; 338():121-8. PubMed ID: 2189135
    [No Abstract]   [Full Text] [Related]  

  • 12. The colony-stimulating factors.
    Henderson G
    Aust Nurses J; 1991 Mar; 20(7):27-8. PubMed ID: 2049007
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that G-CSF is a fibroblast growth factor that induces granulocytes to increase phagocytosis and to present a mature morphology, and that macrophages secrete 45-kd molecules with these activities as well as with G-CSF-like activity.
    Mendoza JF; Cáceres JR; Santiago E; Mora LM; Sánchez L; Corona TM; Machuca C; Zambrano IR; Martínez RD; Weiss-Steider B
    Exp Hematol; 1990 Sep; 18(8):903-10. PubMed ID: 1696904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
    Jakubowski AA; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla MA; Moore MA; Gabrilove J
    N Engl J Med; 1989 Jan; 320(1):38-42. PubMed ID: 2462670
    [No Abstract]   [Full Text] [Related]  

  • 15. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promise of colony-stimulating factors in clinical practice.
    Glaspy JA; Ambersley JM
    Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
    Morstyn G; Lieschke GJ; Sheridan W; Layton J; Cebon J; Fox RM
    Semin Hematol; 1989 Apr; 26(2 Suppl 2):9-13. PubMed ID: 2471275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future strategies in the control of myelosuppression: the use of colony-stimulating factors.
    Haeuber D
    Oncol Nurs Forum; 1991 Mar; 18(2 Suppl):16-21. PubMed ID: 2047296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical and clinical evaluation of recombinant human macrophage colony-stimulating factor (rhM-CSF).
    Garnick MB; Stoudemire JB
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():356-71; discussion 371-3. PubMed ID: 2182744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.